Cargando…
Hematopoietic Cell Kinase (HCK) Is Essential for NLRP3 Inflammasome Activation and Lipopolysaccharide-Induced Inflammatory Response In Vivo
Activation of the NLRP3 inflammasome results in caspase 1 cleavage, which subsequently leads to IL-1β and IL-18 secretion, as well as pyroptosis, and aberrant activation of the inflammasome is involved in several diseases such as type 2 diabetes, atherosclerosis, multiple sclerosis, Parkinson’s dise...
Autores principales: | Kong, Xiangxi, Liao, Yajin, Zhou, Lujun, Zhang, Ying, Cheng, Jinbo, Yuan, Zengqiang, Wang, Shukun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523510/ https://www.ncbi.nlm.nih.gov/pubmed/33041826 http://dx.doi.org/10.3389/fphar.2020.581011 |
Ejemplares similares
-
The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway
por: Liu, Shuhan, et al.
Publicado: (2022) -
Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice
por: Dong, Yuan, et al.
Publicado: (2020) -
Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells
por: Poh, Ashleigh R., et al.
Publicado: (2015) -
Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021) -
Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative
por: Chakraborty, Manas Pratim, et al.
Publicado: (2021)